Impact of neoadjuvant chemotherapy on the safety and long-term outcomes of patients undergoing immediate breast reconstruction after mastectomy
Authors:
Open Access
- 4 April 2024
- journal article
- research article
- Published by Springer Nature in Breast Cancer
- Vol. 31 (3) , 507-518
Abstract
Background: In breast cancer patients receiving neoadjuvant chemotherapy (NAC), immediate breast reconstruction (IBR) as a breast cancer treatment option remains controversial. We assessed the impact of NAC on surgical and oncological outcomes of patients undergoing IBR. Methods: This was a retrospective multicenter study of 4726 breast cancer cases undergoing IBR. The rate of postoperative complications and survival data were compared between IBR patients who received NAC and those who did not receive NAC. Propensity score matching analysis was performed to mitigate selection bias for survival. Results: Of the total 4726 cases, 473 (10.0%) received NAC. Out of the cases with NAC, 96 (20.3%) experienced postoperative complications, while 744 cases (17.5%) without NAC had postoperative complications. NAC did not significant increase the risk of complications after IBR (Odds ratio, 0.96; 95%CI 0.74–1.25). At the median follow-up time of 76.5 months, 36 patients in the NAC group and 147 patients in the control group developed local recurrences. The 5-year local recurrence-free survival rate was 93.1% in the NAC group and 97.1% in the control group. (P < 0.001). After matching, there was no significant difference between the two groups. Conclusion: IBR after NAC is a safe procedure with an acceptable postoperative complication profile.Keywords
All Related Versions
Funding Information
- Japanese Breast Cancer Society
This publication has 32 references indexed in Scilit:
- Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in JapanBreast Cancer, 2022
- Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancerAnnals of Oncology, 2022
- Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021Annals of Oncology, 2021
- Long-term Oncologic Outcomes of Immediate Breast Reconstruction vs Conventional Mastectomy Alone for Breast Cancer in the Setting of Neoadjuvant ChemotherapyJAMA Surgery, 2020
- The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 editionBreast Cancer, 2019
- Determinants of short and long term outcomes in patients undergoing immediate breast reconstruction following neoadjuvant chemotherapyJournal of Surgical Oncology, 2017
- Neoadjuvant Chemotherapy and Short-term Morbidity in Patients Undergoing Mastectomy With and Without Breast ReconstructionJAMA Surgery, 2014
- Radiotherapy in implant-based immediate breast reconstruction: risk factors, surgical outcomes, and patient-reported outcome measures in a large Swedish multicenter cohortBreast Cancer Research and Treatment, 2013
- Impact of neoadjuvant chemotherapy on rate of tissue expander/implant loss and progression to successful breast reconstruction following mastectomyThe American Journal of Surgery, 2008
- Preoperative chemotherapy in operable breast cancerThe Lancet, 1993